Iranian Journal of Medical Sciences

Document Type : Letter(s) to the Editor

Authors

1 Department of Psychiatry, Hafez Hospital, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran

2 Nutrition Research Center, Department of Clinical Nutrition, School of Nutrition and Food Sciences, Shiraz, Iran

3 Stem Cell Technology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran

Abstract

Schizophrenia, a serious mental disorder, affects 1% to 2% of people globally and has a substantial financial impact on health and social services. 

Keywords

  1. Dubonyte U, Asenjo-Martinez A, Werge T, Lage K, Kirkeby A. Current advancements of modelling schizophrenia using patient-derived induced pluripotent stem cells. Acta Neuropathol Commun. 2022;10:183. doi: 10.1186/s40478-022-01460-2. PubMed PMID: 36527106; PubMed Central PMCID: PMCPMC9756764.
  2. Reddy-Thootkur M, Kraguljac NV, Lahti AC. The role of glutamate and GABA in cognitive dysfunction in schizophrenia and mood disorders - A systematic review of magnetic resonance spectroscopy studies. Schizophr Res. 2022;249:74-84. doi: 10.1016/j.schres.2020.02.001. PubMed PMID: 32107102; PubMed Central PMCID: PMCPMC7874516.
  3. Li M, Gao Y, Wang D, Hu X, Jiang J, Qing Y, et al. Impaired Membrane Lipid Homeostasis in Schizophrenia. Schizophr Bull. 2022;48:1125-35. doi: 10.1093/schbul/sbac011. PubMed PMID: 35751100; PubMed Central PMCID: PMCPMC9434453.
  4. Petric PS, Ifteni P, Popa AV, Teodorescu A. Cerebral Computed Tomographic Findings in Schizophrenia: Relationship to Second-Generation Antipsychotics and Hyperprolactinemia. Healthcare (Basel). 2024;12. doi: 10.3390/healthcare12131343. PubMed PMID: 38998877; PubMed Central PMCID: PMCPMC11241017.
  5. Pacchiarotti I, Murru A, Kotzalidis GD, Bonnin CM, Mazzarini L, Colom F, et al. Hyperprolactinemia and medications for bipolar disorder: systematic review of a neglected issue in clinical practice. Eur Neuropsychopharmacol. 2015;25:1045-59. doi: 10.1016/j.euroneuro.2015.04.007. PubMed PMID: 25937241.
  6. Zhuo C, Hu S, Chen G, Yang L, Cai Z, Tian H, et al. Low-dose lithium adjunct to atypical antipsychotic treatment nearly improved cognitive impairment, deteriorated the gray-matter volume, and decreased the interleukin-6 level in drug-naive patients with first schizophrenia symptoms: a follow-up pilot study. Schizophrenia (Heidelb). 2023;9:71. doi: 10.1038/s41537-023-00400-w. PubMed PMID: 37838729; PubMed Central PMCID: PMCPMC10576794.
  7. Wlodarczyk A, Wiglusz MS, Cubala WJ. Ketogenic diet for schizophrenia: Nutritional approach to antipsychotic treatment. Med Hypotheses. 2018;118:74-7. doi: 10.1016/j.mehy.2018.06.022. PubMed PMID: 30037619.
  8. Homayoun M, Mehrabani D, Edalatmanesh MA, Shariati M. The role of lithium chloride in nutrition and stem cell growth kinetics: A review. International Journal of Nutrition Sciences. 2021;6:6-13.
  9. Homayoon M, Edalatmanesh MA, Moghadas M. Trimethyltin can induce cell death in the entorhinal cortex of rat brain: a histological architecture and neuronal density evaluation of the neuroprotective role of lithium chloride. Comparative Clinical Pathology. 2015;24:605-8. doi: 10.1007/s00580-014-1953-3.
  10. Gallicchio VS. Lithium effects on stem cells-advances in stem cell application in clinical medicine. Adv Cell Sci Tissue Cul. 2018;2:1-11. doi: 10.35841/cell-science.2.1.1-11.
  11. Bartony M, Gallicchio V. Stem Cells, Lithium and Neuropsychiatric Disorders. J Stem Cell Res. 2022;3:1-13. doi: 10.52793/JSCR.2022.3(1)-30.
  12. Zomer HD, Vidane AS, Goncalves NN, Ambrosio CE. Mesenchymal and induced pluripotent stem cells: general insights and clinical perspectives. Stem Cells Cloning. 2015;8:125-34. doi: 10.2147/SCCAA.S88036. PubMed PMID: 26451119; PubMed Central PMCID: PMCPMC4592031.
  13. Gobshtis N, Tfilin M, Fraifeld VE, Turgeman G. Transplantation of mesenchymal stem cells causes long-term alleviation of schizophrenia-like behaviour coupled with increased neurogenesis. Mol Psychiatry. 2021;26:4448-63. doi: 10.1038/s41380-019-0623-x. PubMed PMID: 31827249.
  14. Tsivion-Visbord H, Perets N, Sofer T, Bikovski L, Goldshmit Y, Ruban A, et al. Mesenchymal stem cells derived extracellular vesicles improve behavioral and biochemical deficits in a phencyclidine model of schizophrenia. Transl Psychiatry. 2020;10:305. doi: 10.1038/s41398-020-00988-y. PubMed PMID: 32873780; PubMed Central PMCID: PMCPMC7463024.